StonvexLoading…
StonvexStonvexStonvexCore line items from SDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $441.90M | $363.75M | $282.41M | $187.88M |
Operating Income | $-58.36M | $-15.46M | $-12.58M | $10.36M |
Net Income | $-64.45M | $-17.58M | $-11.90M | $-18.09M |
EPS (Diluted) | $-0.72 | $-0.31 | $-0.08 | $-0.29 |
Total Assets | $246.73M | $223.24M | $191.97M | Not available |
Total Liabilities | $180.49M | $155.25M | $155.19M | Not available |
Cash & Equivalents | $26.86M | $30.85M | $21.20M | $34.52M |
Free Cash Flow OCF − CapEx | $11.25M | $-32.58M | $-20.50M | $-26.85M |
Shares Outstanding | 96.00M | 85.44M | 81.60M | 81.60M |